Pharma Stocks March 17: Zim Laboratories Gains 7.5%, Onyx Biotec Drops 18.3% 

Mumbai, March 17: Pharmaceutical stocks traded on a mixed note on Tuesday, with Zim Laboratories Ltd. share price rising 7.5% to ₹68.85 from its previous close of ₹64.06, while Onyx Biotec Ltd. share price declined sharply by 18.3% to ₹29.00 from ₹35.50, as of 03:02 pm IST.

The sector reflected divergence, where mid- and small-cap counters saw stock-specific moves rather than a unified trend. Select companies logged strong buying interest, while others witnessed steep declines, indicating cautious positioning among investors.

Why Pharmaceutical Stocks Moved

Zim Laboratories Ltd. and Ind-Swift Laboratories Ltd. gained 7.5% and 7.2% respectively, supported by buying momentum in smaller pharma names. Sakar Healthcare Ltd. and Acutaas Chemicals Ltd. also advanced over 6%, suggesting selective accumulation.

On the losing side, Onyx Biotec Ltd. fell 18.3%, marking the sharpest drop among peers. Krebs Biochemicals & Industries Ltd. declined 5.0%, while Haleos Labs Ltd. and Beta Drugs Ltd. slipped between 3% and 4%, reflecting selling pressure in certain counters.

Pharmaceutical Stocks Performance Snapshot

As of 2.58 pm, Among gainers, Zim Laboratories Ltd. led with a 7.5% rise, followed closely by Ind-Swift Laboratories Ltd. at 7.2%. Sakar Healthcare Ltd. climbed 6.2%, while Acutaas Chemicals Ltd. gained 6.1%. Aarey Drugs & Pharmaceuticals Ltd. also moved up 5.8% so far.

As of 2.58 pm, Conversely, Onyx Biotec Ltd. recorded the steepest fall of 18.3%. Krebs Biochemicals & Industries Ltd. dropped 5.0%, Haleos Labs Ltd. fell 3.8%, and Beta Drugs Ltd. declined 3.2%. Hester Biosciences Ltd. also edged lower by 2.5% so far.

About The Sector

India’s pharmaceutical sector comprises companies engaged in formulations, APIs, and specialty chemicals, catering to both domestic and export markets.

The sector is often influenced by regulatory approvals, USFDA inspections, pricing policies, and currency movements, which can lead to stock-specific volatility across listed players.

Conclusion

Pharmaceutical stocks displayed a split trend on March 17, with gains led by Zim Laboratories Ltd. and losses dominated by Onyx Biotec Ltd. The absence of sector-wide triggers kept movements largely stock-driven.

Source: https://www.nseindia.com/